drugset / Trial / NCT00236639

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

NCT00236639

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of topiramate (96, 192, and 256mg daily) with placebo in long-term treatment of obesity.

Timeline

Start
2000-07
Primary completion
Completion
2002-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 96 mg Oral
Subject Topiramate Small molecule 192 mg Oral
Subject Topiramate Small molecule 256 mg Oral

Indications